Open AccessA case of osimertinib-resistant lung adenocarcinoma responded effectively to alternating therapy
Author(s) -
Haruki Hirakawa,
Kazutoshi Komiya,
Chiho Nakashima,
Shinske Ogusu,
Tomomi Nakamura,
Masahide Tanaka,
Koichiro Takahashi,
Yoshiaki Egashira,
Keita Kai,
Shinya Kimura,
Naoko SueokaAragane
Publication year - 2018
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm.2018.11.25
Subject(s) - osimertinib , adenocarcinoma , medicine , lung , oncology , cancer research , cancer , ros1
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom